Condition: Urinary Tract Infections · Sponsor: Locus Biosciences
This is a Phase 2 superiority study of LBP-EC01, a recombinant bacteriophage cocktail, with an initial open-label 3-arm pharmacokinetic (PK) lead-in portion of 30 patients to evaluate the optimal dosing regimen to be used in the subsequent 288 patient blinded portion of the study which will be randomized 1:1 comparing LBP-EC01 + antibiotic versus placebo + antibiotic in patients with a history of prior urinary tract infection (UTI) cased by E. coli. All patients will be required to have an active acute uncomplicated UTI at baseline.
This description comes directly from the study's public registry record.
Locus Clinical Operations · (919) 495-4510 · clinicaloperations@locus-bio.com
Paul Kim · (919) 495-4510 · Paul.kim@locus-bio.com
Always discuss trial participation with your own doctor first.
| Research Site 138 | Fresno, California, United States | Completed |
| Research Site 131 | Lancaster, California, United States | Recruiting |
| Research Site 123 | Los Angeles, California, United States | Recruiting |
| Research Site 125 | Montebello, California, United States | Completed |
| Research Site 152 | Murrieta, California, United States | Recruiting |
| Research Site 137 | San Diego, California, United States | Recruiting |
| Research Site 126 | Tustin, California, United States | Recruiting |
| Research Site 102 | Doral, Florida, United States | Recruiting |
| Research Site 151 | Hialeah, Florida, United States | Recruiting |
| Research Site 140 | Jensen Beach, Florida, United States | Completed |
| Research Site 103 | Miami, Florida, United States | Recruiting |
| Research Site 149 | Miami, Florida, United States | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05488340